Leading global health care company Novo Nordisk is stepping up efforts to curb the climbing obesity incidence in the country as it recently formalized its partnership with Watsons Philippines to make ...

From AI to fintech to pharma, discover stocks experts say could thrive despite market volatility and global economic shifts. See what they're watching.

Wall Street's major averages closed mixed on Friday, with the Nasdaq Composite (COMP:IND) closing at new highs every day of the week, while the Dow (DJI) retreated from the 46k level. The Nasdaq ...

While Pfizer's market cap and dividends are at risk, Novo has a strong competitive position in GLP-1 TAM. Read why I prefer ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in the obesity market.

In a major strategic shift, Novo Nordisk has announced a significant workforce reduction, eliminating approximately 9,000 ...

Novo Nordisk leads globally in GLP-1s despite U.S. pressure, with a strong pipeline, cost cuts, and attractive valuation.

U.S. Food and Drug Administration Commissioner Martin Makary said on Friday that Hims & Hers' Super Bowl advertisement ...

Regulators sent about 100 warning letters this week to drug advertisers, including to Hims & Hers, a major online provider of ...

Novo Nordisk, the drugmaker behind Ozempic, is laying off thousands of workers as it struggles against competition from other ...

The Novo Nordisk RTO mandate could be a strategy to encourage attrition, but if community-building is the goal, additional ...

Danish Embassy and companies joined Quezon City to launch the Philippines’ first Obesity Summit with Novo Nordisk.